SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-001439
Filing Date
2020-01-03
Accepted
2020-01-03 16:18:40
Documents
15
Period of Report
2020-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d859524d8k.htm   iXBRL 8-K 31226
2 EX-1.1 d859524dex11.htm EX-1.1 185633
3 EX-5.1 d859524dex51.htm EX-5.1 7169
7 GRAPHIC g8595241.jpg GRAPHIC 9103
  Complete submission text file 0001193125-20-001439.txt   413681

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20200103.xsd EX-101.SCH 3072
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200103_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200103_pre.xml EX-101.PRE 10954
8 EXTRACTED XBRL INSTANCE DOCUMENT d859524d8k_htm.xml XML 3254
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 20505668
SIC: 2834 Pharmaceutical Preparations